These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15757889)

  • 21. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1).
    Lai A; Sarcevic B; Prall OW; Sutherland RL
    J Biol Chem; 2001 Jul; 276(28):25823-33. PubMed ID: 11337496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.
    Zhang HT; Gui T; Sang Y; Yang J; Li YH; Liang GH; Li T; He QY; Zha ZG
    J Cell Biochem; 2017 Aug; 118(8):2182-2192. PubMed ID: 28059436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1).
    Greeve MA; Allan RK; Harvey JM; Bentel JM
    J Mol Endocrinol; 2004 Jun; 32(3):793-810. PubMed ID: 15171713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
    Mitchell KO; El-Deiry WS
    Cell Growth Differ; 1999 Apr; 10(4):223-30. PubMed ID: 10319992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Myc overexpression and endocrine resistance in breast cancer.
    McNeil CM; Sergio CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar EK; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Henshall SM; Musgrove EA; Sutherland RL
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):147-55. PubMed ID: 17052904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
    Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
    Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Notch1-dependent p21(Waf1/Cip1) expression influences the Notch1 outcome in tumorigenesis.
    Cialfi S; Palermo R; Manca S; De Blasio C; Vargas Romero P; Checquolo S; Bellavia D; Uccelletti D; Saliola M; D'Alessandro A; Zolla L; Gulino A; Screpanti I; Talora C
    Cell Cycle; 2014; 13(13):2046-55. PubMed ID: 24801890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.
    Fritah A; Saucier C; Mester J; Redeuilh G; Sabbah M
    Mol Cell Biol; 2005 Mar; 25(6):2419-30. PubMed ID: 15743834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo.
    Liu M; Casimiro MC; Wang C; Shirley LA; Jiao X; Katiyar S; Ju X; Li Z; Yu Z; Zhou J; Johnson M; Fortina P; Hyslop T; Windle JJ; Pestell RG
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19035-9. PubMed ID: 19858489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
    McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
    Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated expression of the estrogen receptor prevents the down-regulation of p21Waf1/Cip1 in hormone dependent breast cancer cells.
    Zhao H; Yu J; Peltier CP; Davie JR
    J Cell Biochem; 2004 Oct; 93(3):619-28. PubMed ID: 15378598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H; Wu X
    Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins.
    Ezoe S; Matsumura I; Nakata S; Gale K; Ishihara K; Minegishi N; Machii T; Kitamura T; Yamamoto M; Enver T; Kanakura Y
    Blood; 2002 Nov; 100(10):3512-20. PubMed ID: 12393444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
    Pennanen PT; Sarvilinna NS; Ylikomi TJ
    Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
    Sheng G; Bernabe KQ; Guo J; Warner BW
    Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
    Rodrik V; Zheng Y; Harrow F; Chen Y; Foster DA
    Mol Cell Biol; 2005 Sep; 25(17):7917-25. PubMed ID: 16107734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.
    Venditti M; Iwasiow B; Orr FW; Shiu RP
    Int J Cancer; 2002 May; 99(1):35-42. PubMed ID: 11948489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.